HemaSphere
(Jun 2022)
P485: TARGETING HISTONE LYSINE-SPECIFIC DEMETHYLASES BY JIB-04 IMPROVES RESPONSE OF AML CELLS TO VENETOCLAX TREATMENT
- K. Wohlan,
- D. Fan,
- J. Su,
- A. G. Guzman,
- M. A. Goodell,
- R. E. Rau
Affiliations
- K. Wohlan
- 1 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States of America
- D. Fan
- 2 Institute of Biomedical Big Data
- J. Su
- 2 Institute of Biomedical Big Data
- A. G. Guzman
- 1 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States of America
- M. A. Goodell
- 1 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States of America
- R. E. Rau
- 8 Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, Houston, United States of America
- DOI
-
https://doi.org/10.1097/01.HS9.0000844828.78465.7a
- Journal volume & issue
-
Vol. 6
pp.
384
– 385
WeChat QR code